Transparency on trial

Pic:getty/andrewbrookes

Europe launches initiative to transform clinical trials

By Rachel Arthur

Regulatory bodies in the European Union have launched an initiative to develop the region as a focal point for clinical research and to better integrate clinical research in the European health system.

© GettyImages/DNY59

FDA lead calls for independent inquiry into Biogen drug approval

By Jane Byrne

Acting US FDA commissioner, Janet Woodcock, has called for an independent federal review of interactions between officials at her agency and representatives of Biogen, prior to the recent approval of the pharma company’s treatment for Alzheimer’s disease....

(Image: Getty/css0101)

FDA update on COVID-19 actions and advisements

By Jenni Spinner

Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.

(Image: Getty/Shidlovski)

Judge: Feds must open trial data access

By Jenni Spinner

A judge has ruled in favor of parties seeking to broaden access to federal clinical trial information, helping close a long-standing loophole.

(Image: Getty/Ivanmollov)

The potential of blockchain for clinical trials

By Ben Hargreaves

Due to the imperative for secure communication between stakeholders organizing clinical trials, a recent report suggests that blockchain technology could be a ‘perfect’ solution.

(Image: Getty/z_wei)

Sponsors need to understand and prepare for CCPA: Greenphire

By Melissa Fassbender

California’s data privacy law will provide clinical trial participants with confidence that their information will not be misused – though additional clarity is needed as the pharmaceutical industry faces mounting pressure to increase transparency.

Follow us

Products

View more

Webinars